Difference between revisions of "Team:Shanghai Metro/Collaborations"

Line 30: Line 30:
 
                             <li><a href="https://2021.igem.org/Team:Shanghai_Metro/Results"
 
                             <li><a href="https://2021.igem.org/Team:Shanghai_Metro/Results"
 
                                     class="sub-nav-74">Results</a></li>
 
                                     class="sub-nav-74">Results</a></li>
                             <li><a href="https://2021.igem.org/Team:Shanghai_Metro/ProofOfConcept"
+
                             <li><a href="https://2021.igem.org/Team:Shanghai_Metro/Proof_Of_Concept"
 
                                     class="sub-nav-52">Proof Of Concept</a></li>
 
                                     class="sub-nav-52">Proof Of Concept</a></li>
 
                             <li><a href="https://2021.igem.org/Team:Shanghai_Metro/Notebook"
 
                             <li><a href="https://2021.igem.org/Team:Shanghai_Metro/Notebook"
Line 53: Line 53:
 
                     <div class="sub-nav">
 
                     <div class="sub-nav">
 
                         <ul>
 
                         <ul>
                             <li><a href="https://2021.igem.org/Team:Shanghai_Metro/Integrated"
+
                             <li><a href="https://2021.igem.org/Team:Shanghai_Metro/Human_Practices"
 
                                     class="sub-nav-74">Integrated Human Practice</a></li>
 
                                     class="sub-nav-74">Integrated Human Practice</a></li>
 
                             <li><a href="https://2021.igem.org/Team:Shanghai_Metro/Communication"
 
                             <li><a href="https://2021.igem.org/Team:Shanghai_Metro/Communication"

Revision as of 17:06, 1 October 2021

Shanghai_Metro

Team Collaboration with Dr.PHAGE
Since both our team and Dr.Phage team have some members who have done genetic engineering type experiments in the lab before, we decided to enhance the projects of our two groups by sharing our experimental experiences. We helped them by discussing and verifying their experimental steps and inserting our plasmids carrying tke and ike into their E.Coli strains, we may use our research to encrypt their products and prevent unauthorized uses.
Team Dr.PHAGE designed a genetically engineered probiotic guided by arabinoxylan to secrete ClyR to prevent and treat dental caries. And our patented strain protection technology can play the role of protecting strains. Taking this as an opportunity, we converted our opinions through online communication, raised problems we encountered, and expressed our willingness to cooperate. In the end, we decided to carry out various forms of cooperation, including technical and publicity.